MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Parkinson’s disease and human gut microbiota in an Egyptian population: a pilot study

    S. Hashish, M. Hirose, A. Moustafa, A. Shalash, S. Ibrahim, M. Salama (Cairo, Egypt)

    Objective: The main objective of our research is to decipher the association between the gut microbiota and Parkinson's disease in an Egyptian cohort. Background: Parkinson’s…
  • 2023 International Congress

    PD.ai – Detection of Parkinson’s Disease with gait-based biomarkers using AI techniques

    SJS. Rajasekar, A. Stezin (Melmaruvathur, India)

    Objective: This study evaluated the utility of Artificial Intelligence (AI) in detection of patients with Parkinson’s disease from stride dynamics. Background: Parkinson’s Disease (PD) is…
  • 2023 International Congress

    Effects of cerebellar cTBS on motor symptoms in Huntington’s disease: a feasibility and pilot study

    JF. Martin Rodriguez, M. Gomez Crespo, FJ. Gómez Campos, AM. Castellano-Gerrero, V. Villarreal, FJ. Palomar Simón, P. Porcacchia, F. Carrillo, S. Jesús, P. Mir (Sevilla, Spain)

    Objective: To evaluate the feasibility and preliminary clinical effects of a single session of cerebellar cTBS in patients with Huntington's disease (HD) with mild-moderate motor…
  • 2023 International Congress

    Turning 360 degrees in standing – associations with perceived walking difficulties and comfortable gait speed in people with drug naïve/early Parkinson’s disease.

    MH. Nilsson, M. Lindh-Rengifo, E. Stomrud, O. Hansson, SB. Jonasson (Lund, Sweden)

    Objective: To investigate how turning performance (360 degrees in standing) is associated with perceived walking difficulties and comfortable gait speed in people with drug naïve…
  • 2023 International Congress

    Regional Atrophy and Motor Speech in PSP

    H. Clark, J. Stierwalt, F. Ali, H. Botha, K. Josephs, J. Whitwell (ROCHESTER, USA)

    Objective: This study examined the association of regional atrophy on MRI and motor speech in PSP. Background: Motor speech impairment is common in PSP[1]. Although…
  • 2023 International Congress

    Real-world effectiveness and safety of deutetrabenazine in patients with chorea associated with Huntington disease

    V. Sung, A. White, H. Romdhani, D. Goldschmidt, R. Ayyagari, N. Chaijale, A. Yaari, M. Gordon, J. Logan, A. Yang, R. Ribalov (Birmingham, USA)

    Objective: To assess real-world effectiveness and safety of deutetrabenazine (DTBZ) for chorea associated with Huntington disease (HD). Background: Real-world evidence on the impact of DTBZ…
  • 2023 International Congress

    Can radiofrequency lesion be better than DBS?

    J. Brainer, P. Brainer, A. Brainer, P. Brainer (Recife, Brazil)

    Objective: Pallidotomy represents a viable alternative for Parkinson disease(PD) symptoms treatment and has several important advantages, including a decreased need for access to specialists and clinical follow-up, improved affordability, and a lower infection risk, producing high long-term success rates and low morbidity rates. Background: Pallidotomy is recognized as effective for treating the symptoms of Parkinson's disease. Sometimes, radiofrequency may…
  • 2023 International Congress

    Connectomics of Chronic VIM vs Rescue VIM/VO Deep Brain Stimulation in Essential Tremor

    V. Chandra, J. Wong, J. Hilliard, K. Foote, A. Fusco, Y. Mekri (Gainesville, USA)

    Objective: This study aims to use connectomic analysis to determine the difference between fiber pathway activation in patients with ineffective VIM stimulation and effective VIM/VO…
  • 2023 International Congress

    Small Molecule Inhibitors for Precise Inhibition of α-Synuclein Oligomer Generation in Parkinson’s Disease (PD)

    A. Cridland, S. Ball, X. Teng, M. Castellana Cruz, K. Pisani, J. Olano Bringas, P. Villegas, I. Kitchen-Smith, X. Yang, B. Mannini, N. Bengoa-Vergniory, S. Brewerton, B. Li, R. Sivasankaran, J. Popovici-Muller, A. Plowright, J. Thomson, J. Habchi (Cambridge, United Kingdom)

    Objective: To develop small molecule therapeutics for PD that inhibit production of toxic α-synuclein oligomers and reduce aggregate formation, targeting the molecular mechanisms at the…
  • 2023 International Congress

    Late Onset Cerebellar Ataxia in a Patient with a Heterozygous Pathogenic KIF1A Mutation: A Case Report

    D. Sell, K. Minks, D. Sirica, P. Morrison (Rochester, USA)

    Objective: Expand upon the current phenotypic understanding of those with KIF1A-associated neurological disorder (KAND), including late onset progressive cerebellar ataxia (CA). Background: KAND encompasses a group…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley